- Home
- ZEPP vs CLGN Comparison
ZEPP vs CLGN Comparison
Compare ZEPP & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEPP
- CLGN
- Stock Information
- Founded
- ZEPP 2013
- CLGN 2004
- Country
- ZEPP China
- CLGN Israel
- Employees
- ZEPP N/A
- CLGN N/A
- Industry
- ZEPP Computer Manufacturing
- CLGN Industrial Specialties
- Sector
- ZEPP Technology
- CLGN Health Care
- Exchange
- ZEPP Nasdaq
- CLGN Nasdaq
- Market Cap
- ZEPP 48.8M
- CLGN 44.1M
- IPO Year
- ZEPP N/A
- CLGN N/A
- Fundamental
- Price
- ZEPP $3.29
- CLGN $4.29
- Analyst Decision
- ZEPP
- CLGN Strong Buy
- Analyst Count
- ZEPP 0
- CLGN 2
- Target Price
- ZEPP N/A
- CLGN $12.50
- AVG Volume (30 Days)
- ZEPP 11.0K
- CLGN 17.8K
- Earning Date
- ZEPP 11-18-2024
- CLGN 11-27-2024
- Dividend Yield
- ZEPP N/A
- CLGN N/A
- EPS Growth
- ZEPP N/A
- CLGN N/A
- EPS
- ZEPP N/A
- CLGN N/A
- Revenue
- ZEPP $237,238,260.00
- CLGN $689,000.00
- Revenue This Year
- ZEPP N/A
- CLGN N/A
- Revenue Next Year
- ZEPP $18.83
- CLGN $670.03
- P/E Ratio
- ZEPP N/A
- CLGN N/A
- Revenue Growth
- ZEPP N/A
- CLGN N/A
- 52 Week Low
- ZEPP $2.06
- CLGN $3.61
- 52 Week High
- ZEPP $8.40
- CLGN $6.99
- Technical
- Relative Strength Index (RSI)
- ZEPP 40.51
- CLGN 54.40
- Support Level
- ZEPP $3.00
- CLGN $3.61
- Resistance Level
- ZEPP $3.43
- CLGN $4.58
- Average True Range (ATR)
- ZEPP 0.19
- CLGN 0.23
- MACD
- ZEPP -0.02
- CLGN 0.09
- Stochastic Oscillator
- ZEPP 21.51
- CLGN 69.59
About ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in two segments: Xiaomi Wearable Products and Self-branded products & others. The product portfolio includes smartwatches and fitness bands. The majority is from Self-branded products & other segments. It generates majority of the revenue from Xiaomi Wearable Products segment.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.